Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0376358 (
prostate cancer
)
59,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein homeostasis, or proteostasis, is required for mitochondrial function, but its role in cancer is controversial. Here we show that transgenic mice expressing the mitochondrial chaperone
TNFR-associated protein 1
(
TRAP1
) in the prostate develop epithelial hyperplasia and cellular atypia. When examined on a Pten
+/-
background, a common alteration in human
prostate cancer
,
TRAP1
transgenic mice showed accelerated incidence of invasive prostatic adenocarcinoma, characterized by increased cell proliferation and reduced apoptosis, in situ Conversely, homozygous deletion of
TRAP1
delays prostatic tumorigenesis in Pten
+/-
mice without affecting hyperplasia or prostatic intraepithelial neoplasia. Global profiling of Pten
+/-
-
TRAP1
transgenic mice by RNA sequencing and reverse phase protein array reveals modulation of oncogenic networks of cell proliferation, apoptosis, cell motility, and DNA damage. Mechanistically, reconstitution of Pten
+/-
prostatic epithelial cells with
TRAP1
increases cell proliferation, reduces apoptosis, and promotes cell invasion without changes in mitochondrial bioenergetics. Therefore,
TRAP1
is a driver of
prostate cancer
in vivo and an "actionable" therapeutic target.
...
PMID:Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development. 2775 70